---
title: "Iambic Therapeutics tumbles 8% during regular trading"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/305342328.md"
description: "Iambic Therapeutics fell 8.16% to US$14.13. Up 21.39% over five sessions and down 11.69% from first-day open."
datetime: "2026-11-12T15:29:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/305342328.md)
  - [en](https://longbridge.com/en/news/305342328.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/305342328.md)
generator: "portal-rs"
---

# Iambic Therapeutics tumbles 8% during regular trading

Iambic Therapeutics (IAM.US) tumbled more than **8%** during regular trading to **$14.13**.

The stock is up 21.39% over the past five sessions and down 11.69% from its first-day open. It sits 43.48% below its 52-week high of US$25.00.

The Nasdaq Composite is up 4.14% over the past five sessions and up 8.95% year to date.

The biotechnology industry index fell 1.2% over the same period.

Based on public media reports. AI-generated; not investment advice.

### Related Stocks

- [IAM.US](https://longbridge.com/en/quote/IAM.US.md)

## Related News & Research

- [Iambic Therapeutics, Inc. GAAP EPS of -$8.52 misses by $7.75, revenue of $11.4M beats by $3.11M](https://longbridge.com/en/news/305698417.md)
- [IAM: Pipeline progress and $455M pro forma cash position support planned 2027 milestones](https://longbridge.com/en/news/305676390.md)
- [Bank of America Names 2 'Strong Buy' Stocks With 60%+ Upside](https://longbridge.com/en/news/305294459.md)
- [Iambic CEO Joins AI Drug Discovery Panel at Jefferies Global Healthcare Conference](https://longbridge.com/en/news/304855723.md)
- [QUOTES-People react to US AI chip curbs that threaten data centre boom](https://longbridge.com/en/news/305767058.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**